Alpha Tau Medical (DRTS) Cash & Equivalents (2020 - 2026)
Alpha Tau Medical (DRTS) posted Cash & Equivalents of $4.6 million for Q1 2026, down 62.01% sequentially from $12.2 million in Q4 2025, and down 7.63% YoY from $5.0 million in Q1 2025.
Alpha Tau Medical (DRTS) Cash & Equivalents (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Cash & Equivalents for 7 years, with the latest figure at $4.6 million in Q1 2026.
- Quarterly Cash & Equivalents fell 7.63% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 7.63% YoY) and the FY2025 annual result came in at $12.2 million, down 11.09% from the prior year.
- Cash & Equivalents retreated to $4.6 million in Q1 2026 per DRTS's latest filing, from $12.2 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $98.9 million in Q1 2022 and troughed at $82000.0 in Q3 2023.
- A 5-year average of $12.0 million and a median of $5.8 million in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 99.09% in 2023, then jumped 6639.02% in 2024.
- Over 5 years, Cash & Equivalents stood at $5.8 million in 2022, then soared by 116.88% to $12.7 million in 2023, then advanced by 8.43% to $13.7 million in 2024, then declined by 11.09% to $12.2 million in 2025, then tumbled by 62.01% to $4.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $4.6 million, $12.2 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 3.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 815.44 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.37 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.71 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 104.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.77 Mn |
| Mar 31, 2026 | 4.64 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Sep 30, 2025 | 3.33 Mn |
| Jun 30, 2025 | 11.70 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 13.72 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 12.66 Mn |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 899,000.00 |
| Dec 31, 2022 | 5.84 Mn |
| Sep 30, 2022 | 5.93 Mn |
| Jun 30, 2022 | 12.36 Mn |
| Mar 31, 2022 | 98.91 Mn |
| Dec 31, 2021 | 23.24 Mn |
| Mar 31, 2021 | 11.87 Mn |